Iovance Biotherapeutics Inc (IOVA)
SG&A Expenses
$149.18M
TTM · Period ending: · USD
IOVA SG&A Expenses
Latest reported$149.18Mperiod ending
Latest reported$149.18Mperiod ending
IOVA TTM SG&A Expenses ($7.01K → $149.18M)
TTM SG&A Expenses
High-resolution chart · PNG
IOVA sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 149,176,000 | |
| 147,471,000 | |
| 152,322,000 | |
| 158,425,000 | |
| 163,423,000 | |
| 160,046,000 | |
| 142,365,000 | |
| 129,765,000 | |
| 117,176,000 | |
| 104,913,000 | |
| 106,916,000 | |
| 103,476,000 | |
| 104,405,000 | |
| 108,806,000 | |
| 104,097,000 | |
| 101,483,000 | |
| 94,477,000 | |
| 87,456,000 | |
| 83,664,000 | |
| 75,898,000 | |
| 70,927,000 | |
| 65,973,000 | |
| 60,210,000 | |
| 54,999,000 | |
| 49,112,000 | |
| 45,626,000 | |
| 40,849,000 | |
| 37,502,000 | |
| 34,586,000 | |
| 30,546,000 | |
| 28,430,000 | |
| 26,280,000 | |
| 23,757,000 | |
| 20,858,000 | |
| 18,152,000 | |
| 17,862,000 | |
| 23,770,000 | |
| 27,106,000 | |
| 25,665,000 | |
| 24,507,000 | |
| 16,669,000 | |
| 11,790,000 | |
| 11,872,000 | |
| 11,126,000 | |
| 10,915,000 | |
| 10,279,000 | |
| 9,336,000 | |
| 7,136,913 | |
| 7,146,913 | |
| 6,177,173 | |
| 4,655,086 | |
| 5,146,173 | |
| 4,065,173 | |
| 4,661,913 | |
| 6,477,000 | |
| 7,273,000 | |
| 11,709,000 | |
| 20,894,000 | |
| 19,302,250 | |
| 17,529,327 | |
| 11,882,354 | |
| 1,405,983 | |
| 815,413 | |
| 321,348 | |
| 157,458 | |
| 75,841 | |
| 14,440 | |
| -3,817 | |
| -4,816 | |
| -4,126 | |
| 7,008 |